Vaccine against Epstein-Barr Virus
US4707358A · kind A · utility
26Cited by
0References
2Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 23, 1984 |
| Grant date | Nov 17, 1987 |
| Priority date | — |
| Expiry date | Jul 23, 2004 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S930/224
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The nucleotide sequence of Epstein-Barr Virus (EBV) DNA which codes for outer surface viral proteins has been determined. Fragments of the DNA have been isolated and cloned into a vector which, when placed in a host organism, express proteins which when used to immunize rabbits generate antibody which reacts with the surface proteins of virus infected cells. These proteins are useful for preparation of a vaccine for EBV.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.